Microbiology & Infectious Diseases is the premier global open access, peer-reviewed journal with Impact Factor: 0.29 considers articles on all aspects of the prevention, diagnosis and management of infectious diseases and covers the topics dealing with the epidemiology, clinical diagnosis antibiotics, treatment, and control of infectious diseases with particular emphasis placed on those diseases that are most common in under-resourced countries. Microbiology & Infectious Diseases encourages research, education, and dissemination of knowledge in the field of Infectious Diseases across the world thus promoting translational research by striking a synergy between basic science, clinical medicine, and public health.
The Journal invites Original Articles, Clinical Investigations, Epidemiological Analysis, Data Protocols, Case Reports, Clinical Photographs, Editorials, Review Articles and special commentaries.
Our journal strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. Microbiology & Infectious Diseases will keep up-to-date with the latest advancements in the feilds of microbiology and infectious diseases. Abstracts and Pdfs of all articles published are freely available to everyone immediately after publication.
Authors are requested to submit manuscripts as an e-mail attachment to the Editorial Office at microbiology@scivisionjournals.com.
Title(s): Microbiology & infectious diseases.
Publication Start Year: 2017
Frequency: Bimonthly
Country of Publication: United States
Publisher: Wilmington, DE : SCiVision Publishers, LLC, [2017]-
Language: English
ISSN: 2639-9458 (Electronic)
LCCN: 2018203136
Other ID: (OCoLC)1057897253
NLM ID: 9918351272706676 [Serial]
Our Articles at 
Recent Articles
Elevated Cardiopulmonary Complications after Revascularization in Patients with Severe Mental Health Disorders
Authors: Leah Gober, Adam Brown, Avianne P Bunnell, Brian E Bunnell, Jean Marie Ruddy
DOI: 10.33425/2639-8486.1122
Maternal Hyperglycemia Induces Changes in Gene Expression and Morphology in Mouse Placentas
Authors: Molly Eckmann, Quanhu Sheng, Scott Baldwin H, Rolanda L Lister.
DOI: 10.33425/2639-9342.1140
Ovarian Stimulation Increases the Risk of Fetal Cardiac Defects of Pups Exposed to Severe Maternal Hyperglycemia
Authors: Rolanda Lister, Etoi Garrison, Francine Hughes, Scott Baldwin, Bin Zhou.
DOI: 10.33425/2639-9342.1074
Effects of Epigallocatechin-3-Gallate-Palmitate (EC16) on In Vitro Norovirus Infection
Authors: Jiarong Zhong, Douglas Dickinson, Stephen Hsu.
DOI: 10.33425/2639-9458.1139
Epigallocatechin-3-Gallate (EGCG) Inhibits SARS-CoV-2 Infection in Primate Epithelial Cells: (A Short Communication)
Authors: Brett L Hurst, Douglas Dickinson, Stephen Hsu.
DOI: 10.33425/2639-9458.1116
Bactericidal and fungicidal activities of novel ProtecTeaV formulations - alcohol-based hand hygiene and surface disinfectant prototypes containing epigallocatechin-3-gallate-palmitate (EC16)
Authors: Douglas Dickinson, Melissa Del Tufo, Emma Liu, Xueling Shao, Stephen Hsu.
DOI: 10.33425/2639-9458.1135
Sinogram Interpolation Inspired by Single-Image Super Resolution
Authors: Carolyn Christiansen, Gengsheng L Zeng.
DOI: 10.33425/2771-9014.1010
Salmonella arizonae Bacteremia in a 16-Year-Old Male Patient with Cavernoma: A Case Report
Authors: Georgios Bonanos, Panagiota Xaplanteri, Odyssefs Dimitrakopoulos, Alexandra Lekkou, Fotios Tzortzidis
Epidemiology of Gardnerella vaginalis Infections at Thies Regional Hospital Center (Senegal)
Authors: Diagne Rokhaya, Moussa Naimatou, Ka Roughyatou, Diop Halimatou, Diop Oumar, Diop Amadou, Sarr Habibou, Niang Aissatou Ahmet, Dièye Baidy, Sow Ahmad Iyane
Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation
Authors: Hirsch, Roberto R, Carvallo, Hector E
Drug Recommendations in the Novel Coronavirus Disease (COVID-19) Treatment and Management Guidelines from the Infectious Diseases Society of America
Authors: Masafumi Seki
A Combination of Hyperbaric Oxygen Therapy and Steroid for Treatment of Severe COVID-19
Authors: Murwan Mohamed Saeed, Ahlam Abdulrasoul Musa
Increased Mast Cell Activation may be Responsible for the Critical Conditions in COVID-19 and Targeting Mast Cells and Their Mediators can Bring New Treatment Prospects
Authors: Hülya Uzunismail